M. Palous

MALDI‐TOF MS‐based drug susceptibility testing of pathogens: The example of <i>Candida albicans</i> and fluconazole

Carine Marinach, Alexandre Alanio, M. Palous et al. · PROTEOMICS · 2009 · 133 citations

Microbial Pathogens, Yeast Cells, Drug Resistance +16

Rapid Emergence of Echinocandin Resistance during Candida kefyr Fungemia Treatment with Caspofungin

Arnaud Fekkar, I. Meyer, Jean‐Yves Brossas et al. · Antimicrobial Agents and Chemotherapy · 2013 · 55 citations · Full text

Aspergillus fumigatus harbouring the sole Y121F mutation shows decreased susceptibility to voriconazole but maintained susceptibility to itraconazole and posaconazole

Julien Lescar, I. Meyer, K. Akshita et al. · Journal of Antimicrobial Chemotherapy · 2014 · 48 citations

Aspergillus PCR in Bronchoalveolar Lavage Fluid for the Diagnosis and Prognosis of Aspergillosis in Patients With Hematological and Non-hematological Conditions

Sébastien Imbert, I. Meyer, M. Palous et al. · Frontiers in Microbiology · 2018 · 43 citations · Full text

Performance of Aspergillus PCR in cerebrospinal fluid for the diagnosis of cerebral aspergillosis

Sébastien Imbert, Jean‐Yves Brossas, M. Palous et al. · Clinical Microbiology and Infection · 2017 · 33 citations · Full text

Cerebral Aspergillosis, Cerebrospinal Fluid, Aspergillus Pcr +4